tradingkey.logo
搜尋

Strata Critical Medical Ord Shs Class A

SRTA
添加自選
4.750USD
-0.010-0.21%
收盤 10-29 16:00(美東)
420.23M總市值
8.29本益比TTM

Strata Critical Medical Ord Shs Class A

4.750
-0.010-0.21%

關於 Strata Critical Medical Ord Shs Class A 公司

Strata Critical Medical, Inc. provides time-critical logistics solutions and specialized medical services to healthcare providers across the United States, expanding its portfolio of services through acquisition and organic growth. The Company focuses on the contractual and macro-non-correlated marketplaces for organ logistics and other medical services. Its subsidiary, Trinity Medical Solutions (Trinity), is engaged in the air and ground transportation of human organs for transplant, leveraging its asset-light platform to deliver logistics solutions to its customers across the United States. Trinity provides Organ Placement Services (TOPS) and Logistics Solutions for Transplant Centers and organ procurement organizations (OPOS). The Company also offers a full-service organ transplant service provider offering surgical recovery, NRP services, air and ground logistics and organ placement services.

Strata Critical Medical Ord Shs Class A 簡介

公司代碼- -
公司名稱- -
上市日期- -
CEO- -
員工數量- -
證券類型- -
年結日- -
公司地址- -
城市- -
上市交易所- -
國家- -
郵編- -
電話- -
網址- -
公司代碼- -
上市日期- -
CEO- -

Strata Critical Medical Ord Shs Class A公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Robert S. (Rob) Wiesenthal
Mr. Robert S. (Rob) Wiesenthal
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
5.33M
+0.94%
Mr. Robert S. (Rob) Wiesenthal
Mr. Robert S. (Rob) Wiesenthal
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
5.33M
+0.94%
Mr. William A. Heyburn
Mr. William A. Heyburn
Co-Chief Executive Officer, Chief Financial Officer, Director
Co-Chief Executive Officer, Chief Financial Officer, Director
1.59M
+3.02%
Mr. William A. Heyburn
Mr. William A. Heyburn
Co-Chief Executive Officer, Chief Financial Officer, Director
Co-Chief Executive Officer, Chief Financial Officer, Director
1.59M
+3.02%
Mr. Louis R. Verdetto
Mr. Louis R. Verdetto
Chief Executive Officer - Clinical Services
Chief Executive Officer - Clinical Services
1.13M
-0.51%
Mr. Louis R. Verdetto
Mr. Louis R. Verdetto
Chief Executive Officer - Clinical Services
Chief Executive Officer - Clinical Services
1.13M
-0.51%
Mr. Scott M. Wunsch
Mr. Scott M. Wunsch
Chief Executive Officer - Logistics Business
Chief Executive Officer - Logistics Business
677.78K
-0.84%
Mr. Scott M. Wunsch
Mr. Scott M. Wunsch
Chief Executive Officer - Logistics Business
Chief Executive Officer - Logistics Business
677.78K
-0.84%
Mr. Eric L. Affeldt
Mr. Eric L. Affeldt
Independent Chairman of the Board
Independent Chairman of the Board
581.21K
--
Mr. Edward M. (Ted) Philip
Mr. Edward M. (Ted) Philip
Independent Director
Independent Director
265.08K
+11.66%
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Robert S. (Rob) Wiesenthal
Mr. Robert S. (Rob) Wiesenthal
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
5.33M
+0.94%
Mr. Robert S. (Rob) Wiesenthal
Mr. Robert S. (Rob) Wiesenthal
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
5.33M
+0.94%
Mr. William A. Heyburn
Mr. William A. Heyburn
Co-Chief Executive Officer, Chief Financial Officer, Director
Co-Chief Executive Officer, Chief Financial Officer, Director
1.59M
+3.02%
Mr. William A. Heyburn
Mr. William A. Heyburn
Co-Chief Executive Officer, Chief Financial Officer, Director
Co-Chief Executive Officer, Chief Financial Officer, Director
1.59M
+3.02%
Mr. Louis R. Verdetto
Mr. Louis R. Verdetto
Chief Executive Officer - Clinical Services
Chief Executive Officer - Clinical Services
1.13M
-0.51%
Mr. Louis R. Verdetto
Mr. Louis R. Verdetto
Chief Executive Officer - Clinical Services
Chief Executive Officer - Clinical Services
1.13M
-0.51%

常見問題

Strata Critical Medical Ord Shs Class A的前五大股東是誰?

Strata Critical Medical Ord Shs Class A的前五大股東如下:Mr. Robert S. (Rob) Wiesenthal

哪個業務部門對Strata Critical Medical Ord Shs Class A的收入貢獻最大?

在2026Q4,Other業務部門對Strata Critical Medical Ord Shs Class A的收入貢獻最大,創收45.11M,占總收入的63.71% 。
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有